Finding of no tumor (pT0) in patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer

Analytical and Quantitative Cytology and Histology

Volumn 29, Issue 2, 2007, Pages 79-86

  Prayer Galetti, Tommaso ^a,c   Gardiman, Marina ^a   Sacco, Emilio ^b   Fracalanza, Simonetta ^a   Betto, Giovanni ^a   Pinto, Francesco ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Hormonal treatment, neoadjuvant; Prostate cancer; pT0

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER STAGING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK;

AGED; HORMONES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 33947505715     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Schulman CC, Debruyne FM, Forster G, Selvaggi FP, Zlotta AR, Witjes WP: 4-Years follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer: European Study Group on Neoadjuvant Treatment of Prostate Cancer. Eur Urol 2000;38:706-713
2. Soloway MS, Sharifi R, Wajsman Z, Mcleod D, Wood Jr DP, Puras Baiez A: Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer: The Lupron Depot Neoadjuvant Prostate Cancer Study Group. J Urol 1995;154:424-428
3. Fair WR, Betancourt JE: Update on Memorial Sloan Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer. Mol Urol 2000;4:241-248
4. Schulman CC: Neoadjuvant androgen blockade prior to radical prostatectomy: A retrospective study and critical review. Prostate Suppl 1994;5:9-14
5. Noguchi M, Noda S, Nakashima O, Kojiro M: No residual tumor in a radical prostatectomy specimen after neoadjuvant hormonal therapy for localized prostate cancer. Oncol Rep 2002;9:1075-1080
6. Pettaway CA, Pisters LL, Troncoso P, Slaton J, Finn L, Kamoi K, Logothetis CJ: Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: Feasibility and preliminary results. J Clin Oncol 2000;18:1050-1057
7. Hara I, Miyake H, Hara S, Gotoh A, Eto H, Arakawa S, Kamidono S: Long-term results of neoadjuvant hormonal therapy prior to radical prostatectomy in patients with clinically localized prostate cancer: Biochemical and pathological effects. Hinyokika-Kiyo 2001;47:453-458
8. Pisters LL, Dinney CP, Pettaway CA, Scott SM, Babaian RJ, von Eschenbach AC, Troncoso P: A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer. J Urol 1999;161:509-514
9. Armas OA, Aprikian AG, Melamed J, Cordon-Cardo C, Cohen DW, Erlandson R, Fair WR, Reuter VE: Clinical and pathological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma. Am J Surg Pathol 1994;18:979-991
10. Kollermann J, Feek U, Muiler H, Kaulfuss U, Ochler U, Helpap B, Kollermann MW: Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma. Eur Urol 2000;38:714-720
11. Paulson DF, Robertson JE, Daubert LM, Walther PJ: Radical prostatectomy in stage A prostatic adenocarcinoma. J Urol 1988;140:535-539
12. Larsen MP, Carter HB, Epstein JI: Can stage A1 tumor extent be predicted by transurethral resection tumor volume, percent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease. J Urol 1991;146:1059-1063
13. Zincke H, Blute ML, Fallen MJ, Farrow GM: Radical prostatectomy for stage A adenocarcinoma of the prostate: Staging errors and their implications for treatment recommendations and disease outcome. J Urol 1991;146:1053-1058
14. Epstein JI, Oesterling JE, Walsh PC: The volume and anatomical location of residual tumor in radical prostatectomy specimens removed for stage A1 prostate cancer. J Urol 1988;139:975-979
15. Herkommer K, Kueffer R, Gschwend JE, Hautmann RE, Volkmer BG: Pathological T0 prostate cancer without neoadjuvant therapy: clinical presentation and follow-up. Eur Urol 2004;45:36-41
16. Epstein JI, Walsh PC, Eggleston JC: Prognosis of untreated stage A1 prostate carcinoma: A study of 94 cases with extended follow-up. J Urol 1996;136:837-839
17. Carter HB, Partin AW: Diagnosis and staging of prostate cancer. In Campbell's Urology. Seventh edition. Edited by PC Walsh, AB Retik, ED Vaughan, AJ Wein. Philadelphia: WB Saunders, 1997, pp 2519-2538
18. Cao D, Hafez M, Berg K, Murphy K, Epstein JI: Little or no residual prostate cancer at radical prostatectomy: Vanishing cancer or switched specimen? A microsatellite analysis of specimen identity. Am J Surg Pathol 2005;29:467-473
19. Kollerman J, Hopfenmüller W, Caprano J, Budde A, Weidenfeld H, Weidenfeld M, Helpap B: Prognosis of stage pT0 after prolonged neoadjuvant endocrine therapy of prostate cancer: A matched-pair analysis. Eur Urol 2004;45:42-45
20. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD: Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. JAMA 1997;277:1445-1451
21. Meyer F, Bairati I, Bedard C, Lacombe L, Tetu B, Fradet Y: Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancer. Urology 2001;58:71-77
22. Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr, Lilja H, Scardino PT: Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for a standardized definition. J Clin Oncol 2006;24:3973-3978
23. Sobin LH, Wittekind (Eds.): TNM Classification of Malignant Tumours. Sixth edition. New York, Wiley-Liss, 2002, pp 188-191
24. European Association of Urology (EAU) Guidelines. 2006 edition. Available at http://www.uroweb.nl/files/uploaded_files/guidelines/07%20Prostate%20Cancer. pdf
25. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology v.2.2005. Available at http://www.nccn.org/professionals/ physician_gls/PDF/ prostate.pdf